Breaking News Instant updates and real-time market news.

ALXN

Alexion

$117.29

-3.29 (-2.73%)

06:31
06/14/19
06/14
06:31
06/14/19
06:31

Alexion announces positive Phase 3 extension data for ULTOMIRIS

Alexion announced the presentation of new data demonstrating that ULTOMIRIS, the first and only long-acting C5 complement inhibitor administered every eight weeks, provided consistent efficacy and safety through 52 weeks in the extension1 of the Phase 3 study of ULTOMIRIS and SOLIRIS in complement inhibitor-naive, adult patients with paroxysmal nocturnal hemoglobinuria. Sustained efficacy of ULTOMIRIS was observed on the co-primary endpoints of transfusion avoidance and normalization of lactate dehydrogenase levels and the secondary endpoints of LDH level reduction and breakthrough hemolysis. In an additional sub-study, nearly all patients preferred ULTOMIRIS over SOLIRIS.3 The data will be presented at the Annual Congress of the European Hematology Association, taking place June 13-19 in Amsterdam, Netherlands.

  • 28

    Jun

ALXN Alexion
$117.29

-3.29 (-2.73%)

05/22/19
WEDB
05/22/19
INITIATION
Target $173
WEDB
Outperform
Alexion initiated with an Outperform at Wedbush
Wedbush analyst Laura Chico started Alexion with an Outperform rating and $173 price target.
05/22/19
05/22/19
UPGRADE

Citi assumes coverage of large-cap biotech, upgrades Amgen and Gilead
Citi analyst Mohit Bansal assumed coverage of large-cap biotech stocks, assuming coverage with five Buy ratings -- Amgen (AMGN), Alexion Pharmaceuticals (ALXN), Vertex Pharmaceuticals (VRTX), Gilead Sciences (GILD), and BioMarin Pharmaceutical (BMRN) -- and two Neutral ratings -- Biogen (BIIB) and Regeneron Pharmaceuticals (REGN). Both Amgen and Gilead were upgraded to Buy from Neutral as part of the assumption of coverage. The analyst said he is "more optimistic" on the sector as a whole as he sees many biotechs going "back to basics" by investing in their internal pipelines and filling their pipelines with early stage assets. He suggests looking at large caps again, as many are returning to stability and growth. Bansal does not favor large M&A, suggesting discipline due to "realizing value with big M&As."
05/23/19
GSCO
05/23/19
DOWNGRADE
Target $142
GSCO
Neutral
Alexion assumed with a Neutral from Buy at Goldman Sachs
Goldman Sachs analyst Salveen Richter assumed coverage of Alexion Pharmaceuticals with a Neutral rating and $142 price target. The firm previously had a Buy rating on the shares. While the analyst sees pipeline optionality for the company, he notes a lack of definitive clinical data to date and emerging competition in gene therapy.
05/23/19
05/23/19
INITIATION
Target $173

Outperform
Alexion initiated with an Outperform at Wedbush
As previously reported, Wedbush analyst Laura Chico started Alexion with an Outperform rating and $173 price target, saying its launch of Utomiris "marks a new chapter" in the company's history amid its "conversion process" away from the flagship therapy Soliris. The analyst further contends that Ultomiris "raises the competitive bar" to offset the competition threat for Soliris, noting that the company's rich pipeline of 14 different programs and the attractive valuation add to her positive outlook on Alexion shares.

TODAY'S FREE FLY STORIES

ACER

Acer Therapeutics

$4.34

-14.83 (-77.36%)

11:52
06/25/19
06/25
11:52
06/25/19
11:52
Downgrade
Acer Therapeutics rating change  »

Acer Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

KNX

Knight-Swift

$30.43

0.37 (1.23%)

11:45
06/25/19
06/25
11:45
06/25/19
11:45
Options
Knight Transportation call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

11:45
06/25/19
06/25
11:45
06/25/19
11:45
General news
Breaking General news story  »

Atlanta Federal Reserve…

AMZN

Amazon.com

$1,890.97

-22.46 (-1.17%)

, MSFT

Microsoft

$134.89

-2.91 (-2.11%)

11:44
06/25/19
06/25
11:44
06/25/19
11:44
On The Fly
Microsoft slips as analyst sees stock 'materially overvalued' as Azure 'not AWS' »

Saying that Microsoft…

AMZN

Amazon.com

$1,890.97

-22.46 (-1.17%)

MSFT

Microsoft

$134.89

-2.91 (-2.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 25

    Jun

  • 09

    Jul

  • 10

    Jul

  • 06

    Aug

WPX

WPX Energy

$11.01

-0.02 (-0.18%)

11:35
06/25/19
06/25
11:35
06/25/19
11:35
Options
WPX Energy put volume heavy and directionally bearish »

Bearish flow noted in WPX…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LEN

Lennar

$51.10

-0.31 (-0.60%)

11:34
06/25/19
06/25
11:34
06/25/19
11:34
Hot Stocks
Lennar remains confident in reaching FY19 home delivery target of 50,000 homes »

Expects margins to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 27

    Jun

  • 28

    Jun

LEN

Lennar

$50.94

-0.47 (-0.91%)

11:33
06/25/19
06/25
11:33
06/25/19
11:33
Earnings
Lennar sees Q3 EPS $1.25-$1.35, consensus $1.52 »

Sees Q3 new orders of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 27

    Jun

  • 28

    Jun

11:30
06/25/19
06/25
11:30
06/25/19
11:30
General news
Treasury announced a $75 B batch of auctions for Thursday »

Treasury announced a $75…

ACER

Acer Therapeutics

$4.31

-14.86 (-77.52%)

11:25
06/25/19
06/25
11:25
06/25/19
11:25
Downgrade
Acer Therapeutics rating change  »

Acer Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

CLDR

Cloudera

$5.53

0.005 (0.09%)

11:25
06/25/19
06/25
11:25
06/25/19
11:25
Options
Cloudera call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CODI

Compass Diversified

$19.00

0.345 (1.85%)

11:25
06/25/19
06/25
11:25
06/25/19
11:25
Conference/Events
Compass Diversified to host investor & analyst meeting »

Investor & Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

UMC

UMC

$2.14

-0.01 (-0.47%)

11:23
06/25/19
06/25
11:23
06/25/19
11:23
Upgrade
UMC rating change at CLSA »

UMC upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

ACER

Acer Therapeutics

$4.30

-14.87 (-77.57%)

11:18
06/25/19
06/25
11:18
06/25/19
11:18
Downgrade
Acer Therapeutics rating change at Needham »

Acer Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

IBKR

Interactive Brokers

$52.52

0.07 (0.13%)

, ETFC

E-Trade

$44.03

-0.54 (-1.21%)

11:17
06/25/19
06/25
11:17
06/25/19
11:17
Conference/Events
Sandler O'Neill financial analyst to hold an analyst/industry conference call »

Financial Analyst Repetto…

IBKR

Interactive Brokers

$52.52

0.07 (0.13%)

ETFC

E-Trade

$44.03

-0.54 (-1.21%)

SCHW

Charles Schwab

$39.09

-0.06 (-0.15%)

AMTD

TD Ameritrade

$47.90

-0.19 (-0.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 23

    Jul

  • 06

    Aug

  • 27

    Oct

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
06/25/19
06/25
11:17
06/25/19
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
06/25/19
06/25
11:16
06/25/19
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DLTR

Dollar Tree

$110.51

-2.21 (-1.96%)

11:15
06/25/19
06/25
11:15
06/25/19
11:15
Options
Dollar Tree put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBR

Petrobras

$16.24

-0.34 (-2.05%)

11:05
06/25/19
06/25
11:05
06/25/19
11:05
Options
Petrobras call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

RDS.B

Royal Dutch Shell

$66.83

0.04 (0.06%)

11:02
06/25/19
06/25
11:02
06/25/19
11:02
Conference/Events
Royal Dutch Shell management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 26

    Jun

MSADY

MS&AD Insurance

$0.00

(0.00%)

11:00
06/25/19
06/25
11:00
06/25/19
11:00
Conference/Events
MS&AD Insurance management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 26

    Jun

  • 27

    Jun

DNKN

Dunkin' Brands

$79.51

-1.5 (-1.85%)

, GRUB

GrubHub

$75.00

2.95 (4.09%)

11:00
06/25/19
06/25
11:00
06/25/19
11:00
On The Fly
Grubhub upgrade, Brighthouse downgrades among today's top analyst actions »

Check out today's top…

DNKN

Dunkin' Brands

$79.51

-1.5 (-1.85%)

GRUB

GrubHub

$75.00

2.95 (4.09%)

BHF

Brighthouse Financial

$34.28

-3.82 (-10.03%)

MSFT

Microsoft

$135.30

-2.5 (-1.81%)

AMZN

Amazon.com

$1,887.85

-25.58 (-1.34%)

SHAK

Shake Shack

$67.38

0.7 (1.05%)

CMG

Chipotle

$735.05

10.91 (1.51%)

SBUX

Starbucks

$84.19

0.54 (0.65%)

MCD

McDonald's

$204.99

1.07 (0.52%)

YUM

Yum! Brands

$110.44

-0.18 (-0.16%)

WEN

Wendy's

$19.21

0.06 (0.31%)

JACK

Jack in the Box

$81.61

-1.22 (-1.47%)

TIF

Tiffany

$90.50

-1.36 (-1.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 25

    Jun

  • 25

    Jun

  • 27

    Jun

  • 09

    Jul

  • 09

    Jul

  • 09

    Jul

  • 10

    Jul

  • 23

    Jul

  • 26

    Jul

  • 06

    Aug

  • 08

    Aug

  • 14

    Aug

  • 14

    Aug

  • 13

    Nov

11:00
06/25/19
06/25
11:00
06/25/19
11:00
General news
The U.S. consumer confidence drop to a 2-year low »

The U.S. consumer…

HR

Healthcare Realty Trust

$32.43

0.23 (0.71%)

10:59
06/25/19
06/25
10:59
06/25/19
10:59
Conference/Events
Healthcare Realty Trust management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 26

    Jun

UN

Unilever; also tag UL

$61.77

-0.11 (-0.18%)

, UL

Unilever; also tag UN

$62.81

-0.11 (-0.17%)

10:59
06/25/19
06/25
10:59
06/25/19
10:59
Periodicals
Unilever to close Nevada plant, impacting about 300 jobs, Reuters reports »

Unilever plans to close…

UN

Unilever; also tag UL

$61.77

-0.11 (-0.18%)

UL

Unilever; also tag UN

$62.81

-0.11 (-0.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BCKIF

Babcock

$0.00

(0.00%)

10:57
06/25/19
06/25
10:57
06/25/19
10:57
Conference/Events
Babcock management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 26

    Jun

  • 27

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.